4.5 Article

Clinical epidemiology of HIV/AIDS in China from 2004-2011

Journal

BIOSCIENCE TRENDS
Volume 8, Issue 1, Pages 52-58

Publisher

IRCA-BSSA
DOI: 10.5582/bst.8.52

Keywords

HIV/AIDS; clinical epidemiology; China

Categories

Funding

  1. 12th Five-Year Infectious Disease Research Project: The Use and Optimization of the Standard Regimen for Diagnosis and Treatment of Tuberculosis in HIV/AIDS Patients in China [2012ZX10001-003]
  2. 12th Five-Year Major Science and Technology Project on Discovery of Major New Drugs: Construction of a Technology Platform for Clinical Evaluation of Anti-HIV Drugs [2012ZX09303013]
  3. Three Year Action Plan to Enhance Development of the Public Health System in Shanghai: Construction of Dedicated Medical Facilities for AIDS Treatment in Shanghai [GW III-13]

Ask authors/readers for more resources

This study retrospectively analyzed Chinese publicly reported data on Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS). The HIV/AIDS morbidity (1/100,000) and mortality (1/100,000) rates in China continually increased from 0.23 and 0.06 in 2004 to 1.53 and 0.69 in 2011, respectively. The AIDS case fatality rate decreased yearly from 53.57% in 2008 to 45.11% in 2011, and the fatality rate in rural areas (0.25-0.42%) was higher than that in cities (0.13-0.22%). The number of HIV/AIDS patients discharged from city-level hospitals increased from 329 in 2004 to 7,266 in 2011, and this number was higher than the number of similar patients discharged from county-level (rural) hospitals (the number of HIV/AIDS patients increased from 252 in 2004 to 5,957 in 2011). The factors contributing to these trends include: enhanced physician HIV/AIDS education regarding diagnosis, intervention, monitoring, testing, and treatment; improved safety of blood collection and use; and improved management of HIV/AIDS patients. Therefore, HIV/AIDS prevention and control in rural areas of China is the key to reducing HIV transmission and mortality in China.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available